By: Nasir Hashmi

It's funny how everyone ignores what is happening these days. It's like there is too much information and we just all don't have enough time to process it all, so we can't take lessons from even the small stuff anymore. If we tried to read everything that was published every day we couldn't even do that. Like this massive Cornell clinical study that benefits Chromadex (CDXC) that no investor knows about.
http://weill.cornell.edu/news/releases/wcmc/wcmc_2012/06_14_12-2.shtml